Results 211 to 220 of about 60,261 (261)

AUTONOMIC NEUROPATHY IN OCULAR HYPERTENSION

The Lancet, 1985
By means of a series of cardiovascular autonomic function tests, systemic parasympathetic neuropathy was demonstrated in 41.8% of 189 patients with ocular hypertension and in 2.6% of 76 controls. Parasympathetic neuropathy was significantly more common in patients with narrow-angle hypertension than in those with wide-angle hypertension.
C V, Clark, R, Mapstone
openaire   +2 more sources

Modern view on ocular hypertension

Vestnik oftal'mologii, 2019
Increased intraocular pressure is the main, and the only modifiable risk factor in the development of glaucoma. This review analyzes studies on differential diagnostics of ocular hypertension and risk factors of its conversion to glaucoma, and gives recommendations based on literature data for the most correct algorithm for management of patients with ...
V P, Erichev, L A, Panyushkina
openaire   +2 more sources

Risk Factors in Ocular Hypertension

European Journal of Ophthalmology, 1997
The aim of the study was to determine whether certain factors are related to an increased risk of developing open-angle glaucoma. A total of 345 untreated glaucoma suspects with intraocular pressure (IOP) ≥ 21 mmHg, cup to disc ratio 0.4 or less and no visual field defects, were followed up for 6 to 8 years (mean 7.3). During the follow-up 71 patients
G, Georgopoulos, D, Andreanos, N, Liokis, D, Papakonstantinou, J, Vergados, G, Theodossiadis   +5 more
openaire   +2 more sources

Emerging drugs for ocular hypertension

Expert Opinion on Emerging Drugs, 2011
Glaucoma is a prevalent ocular disease with characteristic optic disc and visual field changes. Globally, it is the second most common cause of visual disability, and the most common cause of irreversible and preventable blindness. Ocular hypertension (OH) occurs where intraocular pressure elevation occurs in the absence of glaucomatous disc and visual
Anne J, Lee, Ivan, Goldberg
openaire   +2 more sources

Ocular Hypertension Treatment Study

Journal of Glaucoma, 1993
This report relates the design and conduct considerations in the planning of a large, multicenter clinical trial on the treatment of ocular hypertension. This trial will begin patient enrollment in January 1994.
M O, Gordon, M A, Kass
openaire   +2 more sources

New treatments for ocular hypertension

Autonomic Neuroscience, 2009
Glaucoma is a neurodegenerative pathology that affects the optic nerve producing blindness. This disease is often a consequence of an abnormal increase of intraocular pressure (IOP) due to a reduction in the ability of the eye to drain a transparent fluid termed aqueous humour.
Aránzazu, Mediero, Pilar, Alarma-Estrany, Jesús, Pintor   +2 more
openaire   +2 more sources

Triamcinolone Acetonide–Induced Ocular Hypertension

Journal of Ocular Pharmacology and Therapeutics, 2006
The aim of this study is to report on the clinical course of a patient showing markedly increased intraocular pressure (IOP) caused by intravitreal triamcinolone acetonide.A 33-year-old patient received an intravitreal injection of approximately 20 mg of triamcinolone acetonide (TA) as treatment of otherwise therapy-resistant uveitis.
Jost B, Jonas, Gangolf, Sauder, Wido M, Budde, Ulrich H M, Spandau, Bernd A, Kamppeter, Bjoern, Harder   +5 more
openaire   +2 more sources

AN OCULAR HYPERTENSION INDICATOR (TONOMETER)

Journal of the American Medical Association, 1950
The ocular hypertension indicator (tonometer) is a screening instrument and not a diagnostic instrument. We believe that this instrument, placed in the hands of general practitioners according to some acceptable plan, may prevent blindness through the earlier discovery of hypertension and earlier reference of the patient to an ophthalmologist.
C, BERENS, C P, TOLMAN
openaire   +2 more sources

Cerebral hemodynamics in ocular hypertension

Graefe's Archive for Clinical and Experimental Ophthalmology, 2004
To evaluate the cerebral blood flow velocity in patients with ocular hypertension.Twenty-four ocular hypertensive patients and 24 age- and sex-matched healthy volunteers were recruited in a prospective comparative study. All subjects had normal findings on full-threshold visual field tests and clinically normal optic nerves.
Akarsu, Cengiz, Bilgili, Yasemin Karadeniz, Ünal, Birsen, Taner, Pelin, Ergin, Ahmet, Kara, Simay Altan   +5 more
openaire   +3 more sources

When to treat ocular hypertension

Survey of Ophthalmology, 1983
Ocular hypertension (intraocular pressure greater than or equal to 21 mm Hg, normal visual fields, normal optic discs, open angles, and the absence of any contributing ocular disease) occurs in 4-10% of the population over age 40. The question of whether to treat ocular hypertensive patients remains controversial.
openaire   +2 more sources